Vas Narasimhan

0:24:07

Novartis CEO Vas Narasimhan on The David Rubenstein Show

0:03:45

Novartis not joining the 'frenzy' of weight loss drugs, CEO says

0:03:43

Novartis CEO Vas Narasimhan on the latest research on a breast cancer drug

0:01:27

Vas Narasimhan announcing the AI innovation lab.

0:03:58

Meet our people: Vas Narasimhan

0:09:13

Vas Narasimhan and Sarah Kate Ellis discuss inclusivity.

0:06:32

Leaders Never Go Alone: Vas Narasimhan in conversation with Jennifer Garvey Berger

0:07:51

Watch CNBC's full interview with Novartis CEO Vas Narasimhan

0:04:16

Novartis CEO Vas Narasimhan: Our medicines are starting to take market share and deliver on promises

0:24:06

Leaders with Lacqua: Vasant Narasimhan, Novartis CEO

0:04:43

Novartis CEO: Our leukemia drug Scemblix is a potential $3 billion plus medicine

0:03:56

A message about Managed Access from Vas Narasimhan CEO Novartis

0:00:54

Keep Your Focus on the Purpose: Dr. Vas Narasimhan’s Burst of Wisdom

0:06:52

Hopeful to Accelerate Growth in Second Half: Novartis CEO Vas Narasimhan

0:00:57

Novartis Global CEO Vas Narasimhan: AI's Impact on Pharma and Clinical Trial Realities | N18S

0:29:24

2018 WMIF | 1:1 Fireside Chat: Vasant Narasimhan, MD, CEO, Novartis

0:01:21

Vas explains Radioligand Therapy (RLT)

0:25:17

Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company

0:00:58

Novartis CEO Vas Narasimhan on Covid-19 Antibodies

0:07:36

'I don’t feel pressure from shareholders,' says Novartis CEO Vas Narasimhan

0:09:32

Vasant Narasimhan Novartis CEO On Transforming Pharma Industry

0:04:19

Focus remains on R&D to drive growth of blockbuster drugs, says Novartis CEO

0:01:16

AMR Action Fund Launch -Video Message from Vas Narasimhan, CEO, Novartis

0:33:10

Homeroom with Sal & Vas Narasimhan - Wednesday, July 8